-
1
-
-
0037220136
-
Mouse models orthologous to FGFR3-related skeletal dysplasias
-
DOI 10.1080/15227950307697
-
Brodie SG, Deng CX. 2003. Mouse models orthologous to FGFR3-related skeletal dysplasias. Pediatr Pathol Mol Med 22:87-103 (Pubitemid 36025754)
-
(2003)
Pediatric Pathology and Molecular Medicine
, vol.22
, Issue.1
, pp. 87-103
-
-
Brodie, S.G.1
Deng, C.-X.2
-
2
-
-
0024339705
-
The heparin-binding (fibroblast) growth factor family of proteins
-
Burgess WH, Maciag T. 1989. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606 (Pubitemid 19172981)
-
(1989)
Annual Review of Biochemistry
, vol.58
, pp. 575-606
-
-
Burgess, W.H.1
Maciag, T.2
-
3
-
-
0032841519
-
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
-
Cappellen D, De O C, Ricol D, et al. 1999. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 23:18-20
-
(1999)
Nat Genet
, vol.23
, pp. 18-20
-
-
Cappellen, D.1
De O, C.2
Ricol, D.3
-
4
-
-
0035263614
-
365Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates lhh/PTHrP signals and causes severe achondroplasia
-
Chen L, Li C, Qiao W, Xu X, Deng C. 2001. A Ser(365)-. Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum Mol Genet 10:457-465 (Pubitemid 32181668)
-
(2001)
Human Molecular Genetics
, vol.10
, Issue.5
, pp. 457-465
-
-
Chen, L.1
Li, C.2
Qiao, W.3
Xu, X.4
Deng, C.5
-
5
-
-
0030922231
-
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
-
DOI 10.1038/ng0797-260
-
Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL. 1997. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260-264 (Pubitemid 27280209)
-
(1997)
Nature Genetics
, vol.16
, Issue.3
, pp. 260-264
-
-
Chesi, M.1
Nardini, E.2
Brents, L.A.3
Schrock, E.4
Ried, T.5
Kuehl, W.M.6
Bergsagel, P.L.7
-
6
-
-
0032695211
-
Uptake and intracellular transport of acidic fibroblast growth factor: Evidence for free and cytoskeleton-anchored fibroblast growth factor receptors
-
Citores L, Wesche J, Kolpakova E, Olsnes S. 1999. Uptake and intracellular transport of acidic fibroblast growth factor: Evidence for free and cytoskeleton-anchored fibroblast growth factor receptors. Mol Biol Cell 10:3835-3848 (Pubitemid 29534029)
-
(1999)
Molecular Biology of the Cell
, vol.10
, Issue.11
, pp. 3835-3848
-
-
Citores, L.1
Wesche, J.2
Kolpakova, E.3
Olsnes, S.4
-
7
-
-
0028880515
-
Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice
-
Coffin JD, Florkiewicz RZ, Neumann J, et al. 1995. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 6:1861-1873
-
(1995)
Mol Biol Cell
, vol.6
, pp. 1861-1873
-
-
Coffin, J.D.1
Florkiewicz, R.Z.2
Neumann, J.3
-
8
-
-
0029928791
-
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
-
DOI 10.1038/ng0496-390
-
Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12:390-397 (Pubitemid 26105928)
-
(1996)
Nature Genetics
, vol.12
, Issue.4
, pp. 390-397
-
-
Colvin, J.S.1
Bohne, B.A.2
Harding, G.W.3
McEwen, D.G.4
Ornitz, D.M.5
-
9
-
-
0031024921
-
Of worms and men: An evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families
-
DOI 10.1007/PL00006120
-
Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M, Birnbaum D. 1997. Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J Mol Evol 44:43-56 (Pubitemid 27030434)
-
(1997)
Journal of Molecular Evolution
, vol.44
, Issue.1
, pp. 43-56
-
-
Coulier, F.1
Pontarotti, P.2
Roubin, R.3
Hartung, H.4
Goldfarb, M.5
Birnbaum, D.6
-
10
-
-
0029917507
-
Fibroblast growth factor receptor 3 is a negative regulator of bone growth
-
DOI 10.1016/S0092-8674(00)81069-7
-
Deng CX, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. 1996 Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921 (Pubitemid 26106860)
-
(1996)
Cell
, vol.84
, Issue.6
, pp. 911-921
-
-
Deng, C.1
Wynshaw-Boris, A.2
Zhou, F.3
Kuo, A.4
Leder, P.5
-
12
-
-
0032759872
-
Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice
-
DOI 10.1359/jbmr.1999.14.11.1909
-
Garofalo S, Kliger-Spatz M, Cooke JL, et al. 1999. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice. J Bone Miner Res 14:1909-1915 (Pubitemid 29521786)
-
(1999)
Journal of Bone and Mineral Research
, vol.14
, Issue.11
, pp. 1909-1915
-
-
Garofalo, S.1
Kliger-Spatz, M.2
Cooke, J.L.3
Wolstin, O.4
Lunstrum, G.P.5
Moshkovitz, S.M.6
Horton, W.A.7
Yayon, A.8
-
13
-
-
0035912715
-
Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome
-
DOI 10.1073/pnas.121183798
-
Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M. 2001. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci USA 98:7182-7187 (Pubitemid 32567923)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.13
, pp. 7182-7187
-
-
Ibrahimi, O.A.1
Eliseenkova, A.V.2
Plotnikov, A.N.3
Yu, K.4
Ornitz, D.M.5
Mohammadi, M.6
-
14
-
-
0347287038
-
Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity
-
DOI 10.1093/hmg/ddh011
-
IbrahimiOA, Zhang F, EliseenkovaAV, Linhardt RJ,MohammadiM. 2004.Proline to argininemutations inFGFreceptors1 and3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement ofFGF binding affinity.HumMolGenet 13:69-78 (Pubitemid 38072136)
-
(2004)
Human Molecular Genetics
, vol.13
, Issue.1
, pp. 69-78
-
-
Ibrahimi, O.A.1
Zhang, F.2
Eliseenkova, A.V.3
Linhardt, R.J.4
Mohammadi, M.5
-
15
-
-
4744372082
-
Evolution of the Fgf and Fgfr gene families
-
DOI 10.1016/j.tig.2004.08.007, PII S0168952504002410
-
Itoh N, Ornitz DM. 2004. Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563-569 (Pubitemid 39314564)
-
(2004)
Trends in Genetics
, vol.20
, Issue.11
, pp. 563-569
-
-
Itoh, N.1
Ornitz, D.M.2
-
16
-
-
0034234569
-
A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos
-
Iwata T, Chen L, Li C, Ovchinnikov DA, Behringer RR, Francomano CA, Deng CX. 2000. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 9:1603-1613 (Pubitemid 30426997)
-
(2000)
Human Molecular Genetics
, vol.9
, Issue.11
, pp. 1603-1613
-
-
Iwata, T.1
Chen, L.2
Li, C.-L.3
Ovchinnikov, D.A.4
Behringer, R.R.5
Francomano, C.A.6
Deng, C.-X.7
-
17
-
-
0035363725
-
Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice
-
Iwata T, Li CL, Deng CX, Francomano CA. 2001. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum Mol Genet 10:1255-1264 (Pubitemid 32600479)
-
(2001)
Human Molecular Genetics
, vol.10
, Issue.12
, pp. 1255-1264
-
-
Iwata, T.1
Li, C.-L.2
Deng, C.-X.3
Francomano, C.A.4
-
18
-
-
20944433657
-
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans
-
DOI 10.1093/hmg/ddi127
-
Logie A, Dunois-Larde C, Rosty C, et al. 2005. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 14:1153-1160 (Pubitemid 40613904)
-
(2005)
Human Molecular Genetics
, vol.14
, Issue.9
, pp. 1153-1160
-
-
Logie, A.1
Dunois-Larde, C.2
Rosty, C.3
Levrel, O.4
Blanche, M.5
Ribeiro, A.6
Gasc, J.-M.7
Jorcano, J.8
Werner, S.9
Satre-Garau, X.10
Thiery, J.P.11
Radvanyi, F.12
-
19
-
-
0032512740
-
Fibroblast variants nonresponsive to fibroblast growth factor 1 are defective in its nuclear translocation
-
DOI 10.1074/jbc.273.7.4197
-
Mehta VB, Connors L, Wang HCR, Chiu IM. 1998. Fibroblast variants nonresponsive to fibroblast growth factor 1 are defective in its nuclear translocation. J Biol Chem 273:4197-4205 (Pubitemid 28103290)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.7
, pp. 4197-4205
-
-
Mehta, V.B.1
Connors, L.2
Wang, H.-C.R.3
Chiu, I.-M.4
-
20
-
-
18144423534
-
Structural basis for fibroblast growth factor receptor activation
-
DOI 10.1016/j.cytogfr.2005.01.008
-
Mohammadi M, Olsen SK, Ibrahimi OA. 2005. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 16:107-137 (Pubitemid 40616111)
-
(2005)
Cytokine and Growth Factor Reviews
, vol.16
, Issue.2
, pp. 107-137
-
-
Mohammadi, M.1
Olsen, S.K.2
Ibrahimi, O.A.3
-
21
-
-
0033981302
-
The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation
-
DOI 10.1128/MCB.20.2.516-522.2000
-
Monsonego-Ornan E, Adar R, Feferman T, Segev O, Yayon A. 2000. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol 20:516-522 (Pubitemid 30023093)
-
(2000)
Molecular and Cellular Biology
, vol.20
, Issue.2
, pp. 516-522
-
-
Monsonego-Ornan, E.1
Adar, R.2
Feferman, T.3
Segev, O.4
Yayon, A.5
-
22
-
-
0029132035
-
Fibroblast-growth-factor receptor mutations in human skeletal disorders
-
Muenke M, Schell U. 1995. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11:308-313
-
(1995)
Trends Genet
, vol.11
, pp. 308-313
-
-
Muenke, M.1
Schell, U.2
-
23
-
-
0030870932
-
Effect of mutation of cytoplasmic receptor domain and of genistein on transport of acidic fibroblast growth factor into cells
-
Muñoz R, Klingenberg O, Wiedlocha A, Rapak A, Falnes PO, Olsnes S. 1997. Effect of mutation of cytoplasmic receptor domain and of genistein on transport of acidic fibroblast growth factor into cells. Oncogene 15:525-536 (Pubitemid 27384730)
-
(1997)
Oncogene
, vol.15
, Issue.5
, pp. 525-536
-
-
Munoz, R.1
Klingenberg, O.2
Wiedlocha, A.3
Rapak, A.4
Falnes, P.O.5
Olsnes, S.6
-
24
-
-
0029935895
-
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
-
DOI 10.1038/ng0696-233
-
Naski MC, Wang Q, Xu J, Ornitz DM. 1996. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 13:233-237 (Pubitemid 26166160)
-
(1996)
Nature Genetics
, vol.13
, Issue.2
, pp. 233-237
-
-
Naski, M.C.1
Wang, Q.2
Xu, J.3
Ornitz, D.M.4
-
25
-
-
10744229159
-
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity
-
DOI 10.1073/pnas.0307287101
-
Olsen SK, Ibrahimi OA, Raucci A, et al. 2004. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc Natl Acad Sci USA 101:935-940 (Pubitemid 38160562)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.4
, pp. 935-940
-
-
Olsen, S.K.1
Ibrahimi, O.A.2
Raucci, A.3
Zhang, F.4
Eliseenkova, A.V.5
Yayon, A.6
Basilico, C.7
Linhardt, R.J.8
Schlessinger, J.9
Mohammadi, M.10
-
26
-
-
18144391965
-
FGF signaling in the developing endochondral skeleton
-
DOI 10.1016/j.cytogfr.2005.02.003
-
Ornitz DM. 2005. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16:205-213 (Pubitemid 40616117)
-
(2005)
Cytokine and Growth Factor Reviews
, vol.16
, Issue.2
, pp. 205-213
-
-
Ornitz, D.M.1
-
27
-
-
0035081241
-
Fibroblast growth factors
-
REVIEWS3005
-
Ornitz DM, ItohN. 2001. Fibroblast growth factors. Genome Biol 2 REVIEWS3005
-
(2001)
Genome Biol
, vol.2
-
-
Ornitz, D.M.1
Itoh, N.2
-
28
-
-
0026665252
-
Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3
-
Ornitz DM, Leder P. 1992. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J Biol Chem 267:16305-16311
-
(1992)
J Biol Chem
, vol.267
, pp. 16305-16311
-
-
Ornitz, D.M.1
Leder, P.2
-
29
-
-
0037097976
-
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
-
DOI 10.1101/gad.990702
-
Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465 (Pubitemid 34686327)
-
(2002)
Genes and Development
, vol.16
, Issue.12
, pp. 1446-1465
-
-
Ornitz, D.M.1
Marie, P.J.2
-
30
-
-
15844368097
-
Receptor specificity of the fibroblast growth factor family
-
DOI 10.1074/jbc.271.25.15292
-
Ornitz DM, Xu JS, Colvin JS, et al. 1996. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297 (Pubitemid 26195013)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.25
, pp. 15292-15297
-
-
Ornitz, D.M.1
Xu, J.2
Colvin, J.S.3
McEwen, D.G.4
MacArthur, C.A.5
Coulier, F.6
Gao, G.7
Goldfarb, M.8
-
31
-
-
0025835670
-
Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation
-
Rapraeger AC, Krufka A, Olwin BB. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708 (Pubitemid 21917092)
-
(1991)
Science
, vol.252
, Issue.5013
, pp. 1705-1708
-
-
Rapraeger, A.C.1
Krufka, A.2
Olwin, B.B.3
-
32
-
-
0036926992
-
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders
-
DOI 10.1038/sj.ejhg.5200883
-
van Rhijn BW, van Tilborg AA, Lurkin I, et al. 2002. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders. Eur J Hum Genet 10:819-824 (Pubitemid 36054563)
-
(2002)
European Journal of Human Genetics
, vol.10
, Issue.12
, pp. 819-824
-
-
Van Rhijn, B.1
Van Tilborg, A.2
Lurkin, I.3
Bonaventure, J.4
De Vries, A.5
Thiery, J.-P.6
Van Der Kwast, T.H.7
Zwarthoff, E.C.8
-
33
-
-
0028093135
-
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
-
DOI 10.1038/371252a0
-
Rousseau F, Bonaventure J, Legeai-Mallet L, et al. 1994. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-254 (Pubitemid 24293024)
-
(1994)
Nature
, vol.371
, Issue.6494
, pp. 252-254
-
-
Rousseau, F.1
Bonaventure, J.2
Legeai-Mallet, L.3
Pelet, A.4
Rozet, J.-M.5
Maroteaux, P.6
Le Merrer, M.7
Munnich, A.8
-
34
-
-
0030021411
-
Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia
-
Rousseau F, Bonaventure J, Legeai-Mallet L, et al. 1996a. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Horm Res 45:108-110 (Pubitemid 26034772)
-
(1996)
Hormone Research
, vol.45
, Issue.1-2
, pp. 108-110
-
-
Rousseau, F.1
Bonaventure, J.2
Legeai-Mallet, L.3
Pelet, A.4
Rozet, J.-M.5
Maroteaux, P.6
Le Merrer, M.7
Munnich, A.8
-
35
-
-
0029937714
-
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
-
DOI 10.1093/hmg/5.4.509
-
Rousseau F, el G V, Delezoide AL, Legeai-Mallet L, Le Merrer M, Munnich A, Bonaventure J. 1996b. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet 5:509-512 (Pubitemid 26101146)
-
(1996)
Human Molecular Genetics
, vol.5
, Issue.4
, pp. 509-512
-
-
Rousseau, F.1
El Ghouzzi, V.2
Delezoide, A.L.3
Legeai-Mallet, L.4
Le Merrer, M.5
Munnich, A.6
Bonaventure, J.7
-
36
-
-
0033635299
-
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
-
Schlessinger J, Plotnikov AN, Ibrahimi OA, et al. 2000. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6:743-750
-
(2000)
Mol Cell
, vol.6
, pp. 743-750
-
-
Schlessinger, J.1
Plotnikov, A.N.2
Ibrahimi, O.A.3
-
37
-
-
0033970893
-
Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice
-
Segev O, Chumakov I, Nevo Z, et al. 2000. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum Mol Genet 9:249-258 (Pubitemid 30052748)
-
(2000)
Human Molecular Genetics
, vol.9
, Issue.2
, pp. 249-258
-
-
Segev, O.1
Chumakov, I.2
Nevo, Z.3
Givol, D.4
Madar-Shapiro, L.5
Sheinin, Y.6
Weinreb, M.7
Yayon, A.8
-
38
-
-
0027964261
-
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
-
DOI 10.1016/0092-8674(94)90302-6
-
Shiang R, Thompson LM, Zhu YZ, et al. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342 (Pubitemid 24241100)
-
(1994)
Cell
, vol.78
, Issue.2
, pp. 335-342
-
-
Shiang, R.1
Thompson, L.M.2
Zhu, Y.-Z.3
Church, D.M.4
Fielder, T.J.5
Bocian, M.6
Winokur, S.T.7
Wasmuth, J.J.8
-
39
-
-
13044278311
-
A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3
-
DOI 10.1073/pnas.96.8.4455
-
Wang Y, Spatz MK, Kannan K, et al. 1999. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci USA 96:4455-4460 (Pubitemid 29190357)
-
(1999)
Proceedings of the National Academy of Sciences of the United States of America
, vol.96
, Issue.8
, pp. 4455-4460
-
-
Wang, Y.1
Spatz, M.K.2
Kannan, K.3
Hayk, H.4
Avivi, A.5
Gorivodsky, M.6
Pines, M.7
Yayon, A.8
Lonai, P.9
Givol, D.10
-
40
-
-
0033986616
-
Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14
-
DOI 10.1016/S0925-4773(99)00241-5, PII S0925477399002415
-
Wang Q, McEwen DG, Ornitz DM. 2000. Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14. Mech Dev 90:283-287 (Pubitemid 30042935)
-
(2000)
Mechanisms of Development
, vol.90
, Issue.2
, pp. 283-287
-
-
Wang, Q.1
McEwen, D.G.2
Ornitz, D.M.3
-
41
-
-
3242700634
-
Signaling, internalization, and intracellular activity of fibroblast growth factor
-
Wiedlocha A, Sorensen V. 2004. Signaling, internalization, and intracellular activity of fibroblast growth factor. Curr Topics Microbiol Immunol 286:45-79 (Pubitemid 38955147)
-
(2004)
Current Topics in Microbiology and Immunology
, vol.286
, pp. 45-79
-
-
Wiedlocha, A.1
Sorensen, V.2
-
42
-
-
17844402791
-
Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations
-
Wilkie AOM. 2005. Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16:187-203
-
(2005)
Cytokine Growth Factor Rev
, vol.16
, pp. 187-203
-
-
Aom, W.1
-
43
-
-
0033007224
-
Genomic structure, mapping, activity and expression of fibroblast growth factor 17
-
DOI 10.1016/S0925-4773(99)00034-9, PII S0925477399000349
-
Xu J, Lawshe A, MacArthur CA, Ornitz DM. 1999. Genomic structure, mapping, activity and expression of fibroblast growth factor 17. Mech Dev 83:165-178 (Pubitemid 29302091)
-
(1999)
Mechanisms of Development
, vol.83
, Issue.1-2
, pp. 165-178
-
-
Xu, J.1
Lawshe, A.2
MacArthur, C.A.3
Ornitz, D.M.4
-
44
-
-
0025976838
-
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
-
Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848 (Pubitemid 121001170)
-
(1991)
Cell
, vol.64
, Issue.4
, pp. 841-848
-
-
Yayon, A.1
Klagsbrun, M.2
Esko, J.D.3
Leder, P.4
Ornitz, D.M.5
-
45
-
-
0034687699
-
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
-
DOI 10.1073/pnas.97.26.14536
-
Yu K, Herr AB, Waksman G, Ornitz DM. 2000. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci USA 97:14536-14541 (Pubitemid 32016611)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.26
, pp. 14536-14541
-
-
Yu, K.1
Herr, A.B.2
Waksman, G.3
Ornitz, D.M.4
|